scorecardresearch
Tuesday, July 22, 2025
TopicCentral Drugs Standard Control Organization

Topic: Central Drugs Standard Control Organization

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Hand sanitiser makers under govt scanner after complaints of ‘substandard’ products

Govt has collected samples of all kinds of hand sanitisers — from local products to top selling brands such as Dettol, Himalaya, Godrej, Savlon — for quality check.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

After complaint, Modi govt asks states to keep vigil to stop ‘black-marketing’ of remdesivir

The order comes after the govt received a complaint from LocalCircles, saying the drug, whose MRP is Rs 5,400, is being sold at a price of between Rs 15,000 and Rs 60,000. 

Hetero Labs in Hyderabad seeks nod from govt to market remdesivir, a potential Covid drug

Hetero Labs filed an application with the Central Drugs Standard Control Organisation (CDSCO) last week. The CDSCO may soon reach out to ICMR for suggestions.

Himachal govt to file FIR against cough syrup makers ‘responsible’ for 10 infant deaths 

The Coldbest-PC cough syrup, manufactured by the Himachal-based Digital Vision firm, has allegedly led to deaths of 9 infants in J&K and one in Haryana. 

US approves first medicine for treatment of ‘rare’ thyroid eye disease

The medicine approved by US Food and Drug Administration is called Tepezza, which is manufactured by Irish drugmaker Horizon Therapeutics. 

US flags two top neurological drugs used in India, warns of serious breathing difficulties

US Food and Drug Administration says gabapentin and pregabalin drugs, sold in India to treat neurological disorders, may also harm nervous system.

Explained: Why India, US haven’t recalled acidity drug Ranitidine but France & Canada have

US expert who flagged the presence of cancer-causing NDMA in Ranitidine says sales must stop permanently.

On Camera

India’s TRP ecosystem needs a reset. Time to end BARC monopoly

A ratings monopoly in India has led to lack of technological variation, resulting in sluggish systems detached from market dynamics.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.